//
Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Ihab Kamel, M.D., Ph.D.

Associate Professor
(410)955-2906 (p)
Interests

Radiology and Radiological Sciences

Titles

Associate Professor of Radiology Body Imaging

Training

Residency: Radiology, New York Medical College, Valhalla, NY
Fellowship: Body Imaging, BID Medical Center, Boston, MA

 

Journal Citations

Kamel, I.R.; Bluemke, D.A.; Eng, J.; Liapi, E.; Messersmith, W.; Reyes, D.K.; Geschwind, J.F. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol. 2006 Mar;17(3):505-512.

Anders, R.A.; Kamel, I.R. Biopsy considerations in the diagnosis of hepatic masses. Clin Gastroenterol Hepatol. 2007 May;5(5):541-544.

Buijs, M.; Kamel, I.R.; Vossen, J.A.; Georgiades, C.S.; Hong, K.; Geschwind, J.F. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007 Aug;18(8):957-963.

Dorfman, J.D.; Schulick, R.; Choti, M.A.; Geschwind, J.F.; Kamel, I.; Torbenson, M.; Thuluvath, P.J. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol. 2007 Feb 7;13(5):781-784.

Kamel, I.R.; Reyes, D.K.; Liapi, E.; Bluemke, D.A.; Geschwind, J.F. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):49-56.

Buijs, M.; Vossen, J.A.; Hong, K.; Georgiades, C.S.; Geschwind, J.F.; Kamel, I.R. Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI. AJR Am J Roentgenol. 2008 Jul;191(1):285-289.

Chang, K.J.; Kamel, I.R.; Macura, K.J.; Bluemke, D.A. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics. 2008 Nov-Dec;28(7):1983-1998.

El-Khouli, R.H.; Geschwind, J.F.; Bluemke, D.A.; Kamel, I.R. Solitary fibrous tumor of the liver: magnetic resonance imaging evaluation and treatment with transarterial chemoembolization. J Comput Assist Tomogr. 2008 Sep-Oct;32(5):769-771.

Lee, K.H.; Liapi, E.; Vossen, J.A.; Buijs, M.; Ventura, V.P.; Georgiades, C.; Hong, K.; Kamel, I.; Torbenson, M.S.; Geschwind, J.F. Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol. 2008 Oct;19(10):1490-1496.

Liapi, E.; Geschwind, J.F.; Vossen, J.A.; Buijs, M.; Georgiades, C.S.; Bluemke, D.A.; Kamel, I.R. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol. 2008 Jan;190(1):67-73.

Vossen, J.A.; Kamel, I.R.; Buijs, M.; Liapi, E.; Georgiades, C.S.; Hong, K.; Geschwind, J.F. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr. 2008 May-Jun;32(3):347-352.

Assumpcao, L.; Choti, M.; Pawlik, T.M.; Gecshwind, J.F.; Kamel, I.R. Functional MR imaging as a new paradigm for image guidance. Abdom Imaging. 2009 Nov;34(6):675-685.

Hong, K.; McBride, J.D.; Georgiades, C.S.; Reyes, D.K.; Herman, J.M.; Kamel, I.R.; Geschwind, J.F. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol. 2009 Mar;20(3):360-367.

Jacene, H.A.; Leboulleux, S.; Baba, S.; Chatzifotiadis, D.; Goudarzi, B.; Teytelbaum, O.; Horton, K.M.; Kamel, I.; Macura, K.J.; Tsai, H.L.; Kowalski, J.; Wahl, R.L. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy. J Nucl Med. 2009 Nov;50(11):1760-1769.

Jacobs, M.A.; Ouwerkerk, R.; Kamel, I.; Bottomley, P.A.; Bluemke, D.A.; Kim, H.S. Proton, diffusion-weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study. J Magn Reson Imaging. 2009 Mar;29(3):649-656.

Kamel, I.R.; Liapi, E.; Reyes, D.K.; Zahurak, M.; Bluemke, D.A.; Geschwind, J.F. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology. 2009 Feb;250(2):466-473.

Reyes, D.K.; Vossen, J.A.; Kamel, I.R.; Azad, N.S.; Wahlin, T.A.; Torbenson, M.S.; Choti, M.A.; Geschwind, J.F. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009 Nov-Dec;15(6):526-532.

Reyes, D.K.; Vossen, J.A.; Kamel, I.R.; Azad, N.S.; Wahlin, T.A.; Torbenson, M.S.; Choti, M.A.; Geschwind, J.F. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009 Nov-Dec;15(6):526-532.

Ei Khouli, R.H.; Jacobs, M.A.; Mezban, S.D.; Huang, P.; Kamel, I.R.; Macura, K.J.; Bluemke, D.A. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology. 2010 Jul;256(1):64-73.

 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5222
U.S. 410-955-5222
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.